Endoscopic Management of Tumor Bleeding from Inoperable Gastric Cancer.
- Author:
Young Il KIM
1
;
Il Ju CHOI
Author Information
- Publication Type:Original Article
- Keywords: Stomach neoplasms; Hemorrhage; Endoscopic therapy
- MeSH: Christianity; Diagnosis; Endoscopy; Hemorrhage*; Hemostasis; Humans; Palliative Care; Proton Pump Inhibitors; Secondary Prevention; Stomach Neoplasms*
- From:Clinical Endoscopy 2015;48(2):121-127
- CountryRepublic of Korea
- Language:English
- Abstract: Tumor bleeding is not a rare complication in patients with inoperable gastric cancer. Endoscopy has important roles in the diagnosis and primary treatment of tumor bleeding, similar to its roles in other non-variceal upper gastrointestinal bleeding cases. Although limited studies have been performed, endoscopic therapy has been highly successful in achieving initial hemostasis. One or a combination of endoscopic therapy modalities, such as injection therapy, mechanical therapy, or ablative therapy, can be used for hemostasis in patients with endoscopic stigmata of recent hemorrhage. However, rebleeding after successful hemostasis with endoscopic therapy frequently occurs. Endoscopic therapy may be a treatment option for successfully controlling this rebleeding. Transarterial embolization or palliative surgery should be considered when endoscopic therapy fails. For primary and secondary prevention of tumor bleeding, proton pump inhibitors can be prescribed, although their effectiveness to prevent bleeding remains to be investigated.
